A Phase II Clinical Trial of Sequential Neoadjuvant Chemotherapy with Ifosfamide, Doxorubicin, and Gemcitabine, followed by Cisplatin, Gemcitabine, and Ifosfamide in Locally Advanced Urothelial Cancer: Final Results

INTRODUCTION: Neoadjuvant chemotherapy improves survival in high-risk urothelial cancer. However, the lack of curative alternatives to cisplatin-based chemotherapy is limiting for patients with neuropathy or hearing loss. Sequential chemotherapy is also not well studied in the neoadjuvant setting. W...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Siefker-Radtke, AO, Dinney, CP, Shen, Y, Williams, DL, Kamat, AM, Grossman, HB, Millikan, RE
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2012
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3828072/
https://ncbi.nlm.nih.gov/pubmed/22914978
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.27751
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge